Review
doi: 10.1152/ajpregu.1997.273.5.R1569.
The imidazoline receptor in control of blood pressure by clonidine and allied drugs
Affiliations
- PMID: 9374795
- DOI: 10.1152/ajpregu.1997.273.5.R1569
Item in Clipboard
Review
The imidazoline receptor in control of blood pressure by clonidine and allied drugs
Am J Physiol.
1997 Nov.
Abstract
Clonidine, moxonidine, and rilmenidine are centrally acting antihypertensive agents that lower arterial pressure by inhibiting the tonic activity of sympathoexcitatory neurons in the rostral ventrolateral medulla. Competing hypotheses have been put forward by different investigators to explain the sympathoinhibition evoked by "imidazoline drugs": either via central actions at alpha 2-adrenergic receptors or novel I1-imidazoline receptors. These different perspectives are presented in the accompanying reviews.
Similar articles
-
Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.Eur J Pharmacol. 2005 May 9;514(2-3):191-9. doi: 10.1016/j.ejphar.2005.03.021. Eur J Pharmacol. 2005. PMID: 15910806
-
Central imidazoline- and alpha 2-receptors involved in the cardiovascular actions of centrally acting antihypertensive agents.Ann N Y Acad Sci. 1999 Jun 21;881:279-86. doi: 10.1111/j.1749-6632.1999.tb09370.x. Ann N Y Acad Sci. 1999. PMID: 10415926
-
A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.Cardiovasc Drugs Ther. 1994 Mar;8 Suppl 1:27-41. doi: 10.1007/BF00877082. Cardiovasc Drugs Ther. 1994. PMID: 8068578
-
I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly.Drugs Aging. 2000 Aug;17(2):133-59. doi: 10.2165/00002512-200017020-00005. Drugs Aging. 2000. PMID: 10984201 Review.
-
Central imidazoline (I1) receptors as targets of centrally acting antihypertensives: moxonidine and rilmenidine.J Hypertens. 1997 Feb;15(2):117-25. doi: 10.1097/00004872-199715020-00001. J Hypertens. 1997. PMID: 9469786 Review.
Cited by
-
Noradrenergic modulation of risk/reward decision making.Psychopharmacology (Berl). 2015 Aug;232(15):2681-96. doi: 10.1007/s00213-015-3904-3. Epub 2015 Mar 13. Psychopharmacology (Berl). 2015. PMID: 25761840
-
Brain stem adenosine receptors modulate centrally mediated hypotensive responses in conscious rats: A review.J Adv Res. 2015 May;6(3):331-40. doi: 10.1016/j.jare.2014.12.005. Epub 2014 Dec 18. J Adv Res. 2015. PMID: 26257930 Free PMC article. Review.
-
Agmatine modulates spontaneous activity in neurons of the rat medial habenular complex-a relevant mechanism in the pathophysiology and treatment of depression?Transl Psychiatry. 2018 Sep 24;8(1):201. doi: 10.1038/s41398-018-0254-z. Transl Psychiatry. 2018. PMID: 30250120 Free PMC article.
-
Agmatine : metabolic pathway and spectrum of activity in brain.CNS Drugs. 2007;21(11):885-900. doi: 10.2165/00023210-200721110-00002. CNS Drugs. 2007. PMID: 17927294 Review.
-
Moxonidine for tramadol withdrawal symptoms during detoxification.BMJ Case Rep. 2015 Jul 8;2015:bcr2015210444. doi: 10.1136/bcr-2015-210444. BMJ Case Rep. 2015. PMID: 26156837 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
